252 related articles for article (PubMed ID: 9068023)
1. Glycation and advanced glycation end-product formation with icodextrin and dextrose.
Dawnay AB; Millar DJ
Perit Dial Int; 1997; 17(1):52-8. PubMed ID: 9068023
[TBL] [Abstract][Full Text] [Related]
2. Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin.
Posthuma N; ter Wee PM; Niessen H; Donker AJ; Verbrugh HA; Schalkwijk CG
Perit Dial Int; 2001; 21(1):43-51. PubMed ID: 11280495
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with icodextrin.
Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
Perit Dial Int; 2000; 20 Suppl 5():S39-47. PubMed ID: 11229611
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycosylation end-products in diabetic rats on peritoneal dialysis using various solutions.
Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
Perit Dial Int; 2000; 20(6):643-51. PubMed ID: 11216553
[TBL] [Abstract][Full Text] [Related]
5. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids.
Ueda Y; Miyata T; Goffin E; Yoshino A; Inagi R; Ishibashi Y; Izuhara Y; Saito A; Kurokawa K; Van Ypersele De Strihou C
Kidney Int; 2000 Dec; 58(6):2518-24. PubMed ID: 11115086
[TBL] [Abstract][Full Text] [Related]
6. Icodextrin's effects on peritoneal transport.
Krediet RT; Ho-dac-Pannekeet MM; Imholz AL; Struijk DG
Perit Dial Int; 1997; 17(1):35-41. PubMed ID: 9068020
[TBL] [Abstract][Full Text] [Related]
7. Effects of bicarbonate/lactate solution on peritoneal advanced glycosylation end-product accumulation.
Park MS; Kim JK; Holmes C; Weiss MF
Perit Dial Int; 2000; 20 Suppl 5():S33-8. PubMed ID: 11229610
[TBL] [Abstract][Full Text] [Related]
8. Prevention of membrane damage in patient on peritoneal dialysis with new peritoneal dialysis solutions.
Ahmad M; Shah H; Pliakogiannis T; Oreopoulos DG
Int Urol Nephrol; 2007; 39(1):299-312. PubMed ID: 17004033
[TBL] [Abstract][Full Text] [Related]
9. Analysis of non enzymatic glycosylation in vivo: impact of different dialysis solutions.
Ho-dac-Pannekeet MM; Weiss MF; de Waart DR; Erhard P; Hiralall JK; Krediet RT
Perit Dial Int; 1999; 19 Suppl 2():S68-74. PubMed ID: 10406497
[TBL] [Abstract][Full Text] [Related]
10. Strategies to reduce glucose exposure in peritoneal dialysis patients.
Holmes CJ; Shockley TR
Perit Dial Int; 2000; 20 Suppl 2():S37-41. PubMed ID: 10911641
[TBL] [Abstract][Full Text] [Related]
11. Strategy for preventing peritoneal dialysis failure.
Cancarini G
Contrib Nephrol; 2001; (131):114-24. PubMed ID: 11125557
[No Abstract] [Full Text] [Related]
12. Effects of icodextrin peritoneal dialysis solution on the peritoneal membrane in the STZ-induced diabetic rat model with partial nephrectomy.
Nakao A; Nakao K; Takatori Y; Kojo S; Inoue J; Akagi S; Sugiyama H; Wada J; Makino H
Nephrol Dial Transplant; 2010 May; 25(5):1479-88. PubMed ID: 19759273
[TBL] [Abstract][Full Text] [Related]
13. Comparison of icodextrin- and glucose-based peritoneal dialysis fluids in their acute and chronic effects on human peritoneal mesothelial cells.
Bender TO; Witowski J; Ksiazek K; Jörres A
Int J Artif Organs; 2007 Dec; 30(12):1075-82. PubMed ID: 18203069
[TBL] [Abstract][Full Text] [Related]
14. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
Opatrna S; Popperlova A; Kalousová M; Zima T
Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
[TBL] [Abstract][Full Text] [Related]
15. "NEPP" peritoneal dialysis regimen has beneficial effects on plasma CEL and 3-DG, but not pentosidine, CML, and MGO.
le Poole CY; van Ittersum FJ; Valentijn RM; Teerlink T; Lindholm B; Ter Wee PM; Schalkwijk CG
Perit Dial Int; 2012; 32(1):45-54. PubMed ID: 21632443
[TBL] [Abstract][Full Text] [Related]
16. Biocompatibility of icodextrin.
Cooker LA; Holmes CJ; Hoff CM
Kidney Int Suppl; 2002 Oct; (81):S34-45. PubMed ID: 12230480
[No Abstract] [Full Text] [Related]
17. The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products.
Boulanger E; Wautier MP; Gane P; Mariette C; Devuyst O; Wautier JL
Nephrol Dial Transplant; 2004 Sep; 19(9):2208-16. PubMed ID: 15213320
[TBL] [Abstract][Full Text] [Related]
18. Glucose degradation products and peritoneal membrane function.
Witowski J; Bender TO; Gahl GM; Frei U; Jörres A
Perit Dial Int; 2001; 21(2):201-5. PubMed ID: 11330569
[TBL] [Abstract][Full Text] [Related]
19. Newly Developed Neutralized pH Icodextrin Dialysis Fluid: Nonclinical Evaluation.
Yamaguchi N; Miyamoto K; Murata T; Ishikawa E; Horiuchi T
Artif Organs; 2016 Aug; 40(8):E158-66. PubMed ID: 27530675
[TBL] [Abstract][Full Text] [Related]
20. [Icodextrin in peritoneal dialysis therapy].
Grzegorzewska AE; Antczak-Jedrzejczak D
Przegl Lek; 1999; 56(12):812-6. PubMed ID: 10789195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
